Trial Profile
Phase II, Multi-center, Open-Label, Safety and Tolerance Study of a Novel Malathion Formulation in Infants and Toddlers With Pediculosis Capitis
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 03 Jan 2014
Price :
$35
*
At a glance
- Drugs Malathion (Primary)
- Indications Pediculosis
- Focus Pharmacodynamics
- Sponsors Taro Pharmaceuticals USA
- 03 Jan 2014 New trial record